EFTRW
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW
Delisted
EFTRW was delisted on the 2nd of July, 2024.
11 hedge funds and large institutions have $454K invested in eFFECTOR Therapeutics, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
1
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
+$3K
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
$2.7K |
Top Sellers
1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
$260K |
2 |
Citadel Advisors
Miami,
Florida
|
$0 |
3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
$2.32K |